The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health (Q34110585)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health |
scientific article |
Statements
1 reference
The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health (English)
1 reference
Pablo Tebas
1 reference
Naim M Maalouf
1 reference
Roger J Bedimo
1 reference
Henning Drechsler
1 reference
Mamta Jain
1 reference
James Cutrell
1 reference
Song Zhang
1 reference
Xilong Li
1 reference
Irfan Farukhi
1 reference
Rosinda Castanon
1 reference
29 August 2014
1 reference
29 August 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference